Liu, Jiacong
Huang, Xuhua
Yang, Yuhong
Lv, Wang
Wang, Yiqing
Xia, Pinghui
Hu, Jian
Funding for this research was provided by:
National Key Research and Development Program of China (2022YFC2407303)
Research Center for Lung Tumor Diagnosis and Treatment of Zhejiang Province (JBZX-202007)
Article History
Received: 6 July 2024
Accepted: 26 November 2024
First Online: 29 November 2024
Declarations
:
: This trial was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (2021 IIT No. 844), and done in accordance with the Declaration of Helsinki (as revised in 2013) and Good Clinical Practice Guidelines. Written informed consent was obtained from patients so that we could acquire and use required information from their medical record in our hospital.
: The authors have no conflicts of interest to declare.